Obesity
Postoperative weight loss with anti-obesity medication may decrease risk of revision TJA
Published results showed patients with obesity who took anti-obesity medications and had postoperative weight loss within 1 year after total joint arthroplasty may be at significantly decreased risk for revision at 5 and 10 years.
FDA removes semaglutide from drug shortage list
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can meet present and future demand, Novo Nordisk and the FDA announced.
Unintended weight loss before kidney transplant evaluation tied to lower listing odds
Unintentional weight loss prior to kidney transplant evaluation may be linked to lower listing odds and higher waitlist mortality for frail patients with obesity, a study found.
Top in endocrinology: BP benefits of low-cal keto diet; tirzepatide reduces albuminuria
Researchers found that women with hypertension who followed a very low-calorie ketogenic diet had lower systolic and diastolic blood pressure at 6 months than those who participated in intermittent fasting or had no dietary restrictions.
Q&A: How to partner with parks and recreation to address pediatric obesity
Children with overweight and obesity experienced notable improvements in health outcomes after participating in a lifestyle treatment program through a pediatric obesity clinic and local parks and recreation facility.
Gastric bypass leads to greater long-term excess BMI loss than sleeve gastrectomy
Adults with obesity who underwent Roux-en-Y gastric bypass achieved a greater excess BMI loss at 10 years compared with those who underwent a laparoscopic sleeve gastrectomy, according to data published in JAMA Surgery.
Glomerular hyperfiltration may increase CVD risk for patients with type 2 diabetes
Glomerular hyperfiltration may increase CVD risks, including myocardial infarction and heart failure, for patients with type 2 diabetes, study data show.
No significant change seen in obesity rate for US adults from 2013 to 2023
The percentage of U.S. adults with obesity did not significantly rise from 2013 to 2023, though a small uptick in the rate of obesity was seen for children and adolescents, according to data published in JAMA.
Tirzepatide reduces albuminuria among adults with type 2 diabetes in SURPASS trials
Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio than those receiving comparators such as placebo or another therapy, researchers reported.
‘Alternative’ markers of insulin resistance can predict osteoarthritis
Surrogate measures of insulin resistance, based on the triglyceride-glucose index, can be used to predict the development of osteoarthritis, according to data published in Scientific Reports.